Literature DB >> 2611085

Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

Q Y Yue1, J O Svensson, C Alm, F Sjöqvist, J Säwe.   

Abstract

1. The 8 h urinary excretion of codeine and seven of its metabolites was compared in 149 healthy Swedish Caucasians and 133 healthy Chinese following a single oral dose of 25 mg codeine phosphate. 2. The total 8 h urinary recovery of drug-related material was 74 +/- 24% in the Caucasians and 60 +/- 14% in the Chinese (P less than 0.001). The excretion of unchanged codeine was significantly higher in the Chinese (7.2%) compared with the Caucasians (4.3%, P less than 0.001). 3. The Caucasians excreted significantly greater proportions of codeine-6-glucuronide (C6G) (62%) than the Chinese (44%) (P less than 0.001). The frequency distribution of the log metabolic ratio (MR) for glucuronidation (codeine/C6G) was shifted towards higher values in the Chinese population. Males in both groups and Chinese smokers had significantly lower glucuronidation MRs than females and non-smokers in the respective populations (P less than 0.001). 4. The frequency distribution of the MR for O-demethylation (codeine/morphine (M) + M-3 and M-6-glucuronide (M3G and M6G) + normorphine (NM) was highly skewed in the Caucasians, suggestive of a bimodal distribution. There was a 160-fold interindividual variation in this MR. A unimodal distribution of the log O-demethylation MR was observed in Chinese. The Caucasians excreted less M and more M6G than did the Chinese (P less than 0.001). 5. Significantly more norcodeine (NC) and less NC-glucuronide (NCG) were excreted in the Chinese compared with the Caucasians (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611085      PMCID: PMC1380033          DOI: 10.1111/j.1365-2125.1989.tb03555.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  MORPHINE AND NORMORPHINE IN THE BRAINS OF RATS GIVEN IDENTICALLY ANALGAESIC DOSES OF MORPHINE, CODEINE OR NORMORPHINE.

Authors:  T JOHANNESSON; J SCHOU
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.

Authors:  K Nakamura; F Goto; W A Ray; C B McAllister; E Jacqz; G R Wilkinson; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1985-10       Impact factor: 6.875

3.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography.

Authors:  J O Svensson; A Rane; J Säwe; F Sjöqvist
Journal:  J Chromatogr       Date:  1982-07-09

4.  Tolerance and side effects during long term treatment of hypertension with debrisoquine.

Authors:  W B Jackson
Journal:  Aust N Z J Med       Date:  1972-11

5.  A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.

Authors:  E Steiner; L Iselius; G Alván; J Lindsten; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1985-10       Impact factor: 6.875

6.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Codeine disposition in smokers and nonsmokers.

Authors:  J F Rogers; J W Findlay; J H Hull; R F Butz; E C Jones; J A Bustrack; R M Welch
Journal:  Clin Pharmacol Ther       Date:  1982-08       Impact factor: 6.875

8.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

9.  Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations.

Authors:  M C Williams; J W Goldzieher
Journal:  Steroids       Date:  1980-09       Impact factor: 2.668

10.  Environmental factors affecting paracetamol metabolism in London factory and office workers.

Authors:  J C Mucklow; H S Fraser; C J Bulpitt; C Kahn; G Mould; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

View more
  25 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain.

Authors:  Patrice Villars; Marylin Dodd; Claudia West; Theresa Koetters; Steven M Paul; Karen Schumacher; Debu Tripathy; Peter Koo; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2007-01       Impact factor: 3.612

3.  Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Authors:  I Johansson; Q Y Yue; M L Dahl; M Heim; J Säwe; L Bertilsson; U A Meyer; F Sjöqvist; M Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 5.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

6.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

7.  Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism.

Authors:  Z Liu; O Mortimer; C A Smith; C R Wolf; A Rane
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

8.  The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.

Authors:  Stacy S Shord; Larisa H Cavallari; Weihua Gao; Hyun-Young Jeong; Kelly Deyo; Shitalben R Patel; Joseph R Camp; Susan M Labott; Robert E Molokie
Journal:  Eur J Clin Pharmacol       Date:  2009-04-09       Impact factor: 2.953

9.  Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese.

Authors:  N J Osborne; A L Tonkin; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 10.  Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.